Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
AmorChem Invests in Novel Approach to Target Myc-driven Cancers
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft…
Approval
Allergan’s Durysta Implant Approved to Treat Glaucoma
Phase III
AstraZeneca Bladder Cancer Treatment Fails to Hit the Mark in Phase…
Approval
Novadoz Pharmaceuticals Increases Presence in the Generic Oncology Market with an…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine…
Deals
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients…
Commercial
Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent…
Deals
Announcement of Joint Research Agreement with Nagoya University for Spinal Cord…
Home
Commercial
Lay off/Spin-off/Appointments
Lay off/Spin-off/Appointments
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lay off/Spin-off/Appointments
ElevateBio Appoints Kareem Reda as Chief Business Officer
Firstwordpharma News
-
March 5, 2020
Lay off/Spin-off/Appointments
PsiOxus Therapeutics Announces Clinical Trial with Third Cancer Gene Therapy Treatment and Appointment of New Chief Medical Officer
Lay off/Spin-off/Appointments
Matinas BioPharma Appoints James A. Underberg, M.D. to its MAT9001 Scientific Advisory Board
Lay off/Spin-off/Appointments
Relay Therapeutics Announces Formation of Oncology Advisory Board
Lay off/Spin-off/Appointments
MacroGenics Announces Departure of Chief Medical Officer
Lay off/Spin-off/Appointments
Unum Restructures, Closing Two Clinical Trials and Laying Off 43
Biospace News
-
March 3, 2020
0
Lay off/Spin-off/Appointments
Oncopeptides Strengthens its Organization by Appointing Karolina Vilval as General Counsel
Biospace News
-
March 2, 2020
0
Lay off/Spin-off/Appointments
Mylan and Pfizer Finalize Appointments to Viatris Board of Directors
Biospace News
-
February 27, 2020
0
Lay off/Spin-off/Appointments
Antisense Therapeutics Announces Appointment of US-based Consultant Medical Director
Biospace News
-
February 27, 2020
0
Lay off/Spin-off/Appointments
Immunomedics Appoints Robert W. Azelby to Board of Directors
Biospace News
-
February 27, 2020
0
1
2
3
...
37
Page 1 of 37
- Advertisement -
MOST POPULAR
Breast cancer patients to have further NICE-approved drug combination option on...
January 16, 2020
STA To Market Sarcoma Drug In Australia, New Zealand And SE...
October 14, 2019
Liver Cancer Insight Report: Current Therapies, Drug Pipeline and Outlook
January 29, 2020
Tarsus Pharmaceuticals Raises $60 Million in Series B Financing
January 8, 2020
Load more
HOT NEWS
Others
Dartmouth Study Assesses Fracture Risk for Patients Taking Multiple Medications
Commercial
Esperion Announces Pooled Analyses from Phase 3 LDL-C Lowering Development Program...
Commercial
ESSA Pharma Inc. Reports Results of Annual General Meeting of Shareholders
Infectious diseases
Coronavirus vaccine will take months: biotech exec ...
